Bodybuilders and others who wish to increase muscle growth make use of Dindolyl Methane (or DIM). However there have been some recent reports of health risks that DIM could cause. DIM can cause liver damage if taken in excessive amounts. A related risk is kidney damage, which may result in kidney failure. The possible long term health risks of DIM cause many bodybuilders and athletes think about the question: should I take supplements with DIM?
To increase testosterone production, most people take a diindolylmethane supplemental. Testosterone is believed to function as an androgen, which means that it can trigger hormonal changes in tissues. Studies have proven DIM to mimic the effects both of testosterone and other hormones. Since men produce more testosterone than women do Certain manufacturers have added diindolylmethane to their products in order to boost their competitiveness in male circles. The idea is that men will respond to a product that replicates the effects of testosterone naturally produced.
In the end, many companies market DIM as a cancer-fighter. It is true that diindolylmethane can reduce tumor growth in laboratory animals, however these animals were given the drug, not orally. For humans to achieve the same result, diindolylmethane must be taken in large doses over an extended period of period of time. The animals that were examined did not show symptoms of cancer for several years. However, they all developed liver diseases due to consuming excessive amounts of diindolylmethane. A medical practitioner can give you more information about how DIM is absorbed by the body.
The only way to demonstrate that DIM is effective in treating breast cancer is to do an experiment where cells from healthy breast cells are exposed to high doses of diindolylmethane over a prolonged period of time. There are pros and cons to using DIM, as with any chemical. The ability to mimic hormones is among the advantages. This means that you could create insulin, which can stop the proliferation of cancer cells. The negatives include the fact that diindolylmethane can also produce an extremely harmful chemical known as DMSO. Learn more about 3 3 diindolylmethane here.
One of the most common claims made for diindolylmethane as an option for treating various health issues is that it functions as a natural, anti-fungal, anti-bacterial, and anti-cancer agent. These claims were rejected by the National Institute of Health after an exhaustive review of supporting research. According to the Institute of Chemical Technology, there were no experiments performed to verify this assertion. The Institute of Chemical Safety, conducting an in-depth study of the safety profile for the firestone concluded that the information presented by pharmaceutical companies about the benefits of diindolylmethane to humans were not completely reliable.
In the May 2021 edition of the Journal of Toxicology and Environmental Health, van der Goes, and colleagues. Van der Goes, et al. identified the potential risks of diindolylmethane use, including skin rash and allergic reactions asthma attacks as also headaches, dizziness and respiratory problems. They also said that the recommended daily dose for this chemical is 0.2 milligrams, or about one 10th of a teaspoon. It is not clear what the concentration level is when compounded with other substances. This substance is not safe because it hasn’t been thoroughly examined.
The abstract of the view shows that the use of diindolylmethane for cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism by flavenoids is a possibility to block and prevents accumulation of oxalates and pyruvate metabolites in the renal tubule cells. However, metabiplicate toxicology studies didn’t provide convincing evidence that consumption of this chemical can cause an overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA the company that makes firestone tincture is currently in the process of conducting two major studies – one in Europe and another in the United States.
The view abstract also indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the principle of inhibiting the intracellular inhibition of pyruvate’s pyruvate metabolite via flavenoids, thereby blocking the accumulation of oxalates in renal tubule cells as well as Adenine granulocytes. Metabiplicate toxicology studies on the drug have not proven that this chemical can cause overdose. The Food and Drug Administration approved this substance as a prescription drug in June 1996. According to the FDA, the manufacturer of firestone tincture is in the process of completing two major trials–one in Europe and one in the United States. According to the FDA the company that produces firestone tincture is currently in the process of finishing two major trials in Europe and one in the United States.